PharmEste's Series B - II Round

PharmEste raised a round of funding on June 01, 2011.

PharmEste is a private biopharmaceutical company focused on the discovery and development of Transient Receptor Potential (TRP) channel therapeutics for the treatment of neuropathic pain, and other TR…

Articles about PharmEste's Series B - II Round: